BioWorld

Oct. 28, 2010

View Archived Issues

Sequencing Star PacBio Gets Out IPO Window After Aegerion

The good news is that Pacific Biosciences Inc. raised a hefty $200 million in its initial public offering, pricing at the midpoint of its expected range and closing up on its first day of trading. (BioWorld Today) Read More

GTx Offering to Add $40M, Rebuild Reserves, Buy Time

Read More

'Here There be Dragons' Days of Genomics Drawing to Close

Read More

NewCo News: BMT Takes 'Shorter' Approach to Develop RNAi-Based Drugs

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Earnings Roundup

Read More

U.S. Patent Disclosures

Read More